Title : Influence of SLCO1B1 polymorphisms on lopinavir Ctrough in Serbian HIV/AIDS patients.

Pub. Date : 2020 Jul

PMID : 32022294






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Influence of SLCO1B1 polymorphisms on lopinavir Ctrough inSerbian HIV/AIDS patients. Lopinavir solute carrier organic anion transporter family member 1B1 Homo sapiens
2 Since LPV is a substrate for the SLCO1B1 (OATP1B1)-transporter, the aim of this study was to assess the impact of SLCO1B1 polymorphisms (rs11045819, rs4149032 and rs4149056) on LPV trough plasma concentrations (Ctrough ) in Serbian patients. Lopinavir solute carrier organic anion transporter family member 1B1 Homo sapiens
3 Since LPV is a substrate for the SLCO1B1 (OATP1B1)-transporter, the aim of this study was to assess the impact of SLCO1B1 polymorphisms (rs11045819, rs4149032 and rs4149056) on LPV trough plasma concentrations (Ctrough ) in Serbian patients. Lopinavir solute carrier organic anion transporter family member 1B1 Homo sapiens
4 Since LPV is a substrate for the SLCO1B1 (OATP1B1)-transporter, the aim of this study was to assess the impact of SLCO1B1 polymorphisms (rs11045819, rs4149032 and rs4149056) on LPV trough plasma concentrations (Ctrough ) in Serbian patients. Lopinavir solute carrier organic anion transporter family member 1B1 Homo sapiens
5 In multivariate regression analysis, only the SLCO1B1 rs4149056 polymorphism was independently associated with higher LPV Ctrough [beta=2834.5 (1442-4226.9) ng/mL (p=0.001)]. Lopinavir solute carrier organic anion transporter family member 1B1 Homo sapiens
6 CONCLUSIONS: Our results demonstrate a statistically significant influence of the SLCO1B1 rs4149056 polymorphism on higher LPV Ctrough in Caucasian HIV/AIDS- patients. Lopinavir solute carrier organic anion transporter family member 1B1 Homo sapiens